Skip to main content
Top
Published in: Current Hepatology Reports 4/2018

Open Access 01-12-2018 | Correction

Correction: The Role of Anticoagulation in Treating Portal Hypertension

Authors: Laura Turco, Filippo Schepis, Erica Villa

Published in: Current Hepatology Reports | Issue 4/2018

Login to get access

Excerpt

Correction: Current Hepatology Reports (2018) 17(3):200–208
Metadata
Title
Correction: The Role of Anticoagulation in Treating Portal Hypertension
Authors
Laura Turco
Filippo Schepis
Erica Villa
Publication date
01-12-2018
Publisher
Springer US
Published in
Current Hepatology Reports / Issue 4/2018
Electronic ISSN: 2195-9595
DOI
https://doi.org/10.1007/s11901-018-0443-5

Other articles of this Issue 4/2018

Current Hepatology Reports 4/2018 Go to the issue

Fatty Liver Disease (Z Younossi, Section Editor)

Surgical Issues in NASH: Bariatric Surgery and Liver Transplantation

Hepatic Cancer (A Singal and A Mufti, Section Editors)

LI-RADS v2018: a Primer and Update for Clinicians

Hepatic Cancer (A Singal and A Mufti, Section Editors)

Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma

Hepatic Cancer (A Singal and A Mufti, Section Editors)

Management of Combined Hepatocellular Carcinoma-Cholangiocarcinoma

Fatty Liver Disease (Z Younossi, Section Editor)

Pathogenesis of NASH: the Impact of Multiple Pathways

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.